Semaglutide vs Tirzepatide
These are the two heavyweight molecules of the GLP-1 era. Semaglutide is a GLP-1 receptor agonist (Ozempic, Wegovy). Tirzepatide is a dual agonist that hits both the GLP-1 and GIP receptors (Mounjaro, Zepbound).
In head-to-head and trial data, tirzepatide tends to produce larger average weight loss. But the question that matters for the off-ramp is not just which loses more, it is which loss you can keep, and that comes down to your maintenance plan.
Educational only. This is educational, not medical advice. Everyone's body responds differently. Talk to your clinician before starting, stopping, changing, or tapering any medication, and work with your physician and a registered dietitian to personalize your approach.
At a glance
| Semaglutide | Tirzepatide | |
|---|---|---|
| Brands | Ozempic, Wegovy, Rybelsus | Mounjaro, Zepbound |
| Mechanism | GLP-1 receptor agonist | GLP-1 + GIP dual agonist |
| Avg. weight loss (trials) | ~15% (STEP, 2.4 mg) | ~20%+ (SURMOUNT, top dose) |
| Dosing | Weekly injection (or daily oral) | Weekly injection |
| Maker | Novo Nordisk | Eli Lilly |
How the mechanisms differ
Semaglutide activates the GLP-1 receptor, mimicking the gut hormone that signals fullness and slows gastric emptying.
Tirzepatide adds GIP-receptor activity. The combination appears to amplify appetite and metabolic effects, which is the leading explanation for its larger average weight loss in trials.
Which holds weight better after you stop?
Here is the counterintuitive part: larger loss on treatment can mean a larger rebound at cessation, because there is simply more weight that physiology will defend. Both drugs show substantial regain after stopping in withdrawal studies.
In other words, neither molecule 'holds' weight on its own once it is gone. The drug that holds weight better is the one paired with a maintenance system: protein, resistance training, sleep, and early habits.
Which for whom
- Tirzepatide produces more weight loss on average, but individual response varies and tolerance differs.
- Side-effect experience, cost, coverage, and other conditions all factor in.
- The right molecule for you is a clinician decision based on your full picture, not a leaderboard.
Which holds weight better after you stop?
Whichever you used, the off-ramp physiology is the same: appetite hormones rebound and metabolic rate stays low. The bigger your on-treatment loss, the more deliberate your maintenance plan needs to be.
Building the pillars before you stop, and tracking early after, is what converts a large loss into a kept one.
Frequently asked questions
Does tirzepatide cause more weight loss than semaglutide?
On average in trials, yes; tirzepatide (Zepbound, Mounjaro) produced larger weight loss than semaglutide (Wegovy, Ozempic). Individual response varies, and which is right for you is a clinical decision.
Which is better for keeping weight off after stopping?
Neither holds weight on its own once stopped; both show substantial regain. The deciding factor is your maintenance plan, and larger on-treatment loss means a more deliberate off-ramp is needed.
Sources & further reading
Every claim on this page is drawn from peer-reviewed research, clinical trials, or recognized health authorities. Read the source before making any decision about your health.
- [1]Rebound or Retention: A Meta-Analysis of Weight Regain After Discontinuation of GLP-1 Receptor AgonistsNIH/PMC
- [2]Trajectory of weight regain after cessation of GLP-1 receptor agonists: a systematic review and nonlinear meta-regressionNIH/PMC
- [3]Attenuating the Biologic Drive for Weight Regain Following Weight Loss: Must What Goes Down Always Go Back Up?NIH/PMC